首页 > 最新文献

Revista mexicana de urologia最新文献

英文 中文
Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability 墨西哥年轻人的勃起功能障碍和相关危险因素:伴侣可得性的重要性
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.06.009
C.I. Villeda-Sandoval, M.B. Calao-Pérez, J.O. Herrera-Cáceres, E. González-Cuenca, F. Rodríguez-Covarrubias, R.A. Castillejos-Molina

Objective

To determine the prevalence of ED and associated risk factors among young Mexicans between 18 and 40 years of age.

Methods

An observational, cross-sectional, descriptive and analytic study was conducted. Data collection was achieved through a questionnaire. Participants completed the Urologic Health Survey for Men and the International Index of Erectile Function (IIEF-5) questionnaire. The study also included sociodemographic, clinical, and sexual behavior variables.

Results

Of the 373 questionnaires filled out, only 160 were answered completely and used for the analysis. The mean age was 25.59 ± 5.45 years. The prevalence of ED was 33.7% (mild 17.5%, mild-to-moderate 8.1%, moderate 6.3%, and severe 1.9%). The mean score for non-ED males was 24.38 ± 0.94 versus 15.41 ± 4.81 in the ED group. Univariate analysis showed a significant difference in the items of age (p < 0.01), having a stable sexual partner (p < 0.01), sleeping with the sexual partner (p < 0.01), sexual orientation (p = 0.04), and the number of sexual intercourse episodes per week (p < 0.01). In the multivariate analysis “Not having a stable sexual partner” remained a significant risk factor (p = 0.027, OR = 2.60 [CI 1.11–6.08]).

Conclusions

In our study, young Mexican adults had an ED prevalence of 33.7% and most of the cases were mild (17.5%). Partner availability was important. No organic variables were related to ED.

目的确定18 - 40岁墨西哥年轻人ED患病率及相关危险因素。方法采用观察性、横断面、描述性和分析性研究。通过问卷调查收集数据。参与者完成了男性泌尿系统健康调查和国际勃起功能指数(IIEF-5)问卷。该研究还包括社会人口学、临床和性行为变量。结果在填写的373份问卷中,只有160份被完整回答并用于分析。平均年龄25.59±5.45岁。ED患病率为33.7%(轻度17.5%,轻度至中度8.1%,中度6.3%,重度1.9%)。非ED男性的平均得分为24.38±0.94,ED组为15.41±4.81。单因素分析显示,年龄项有显著差异(p <0.01),有稳定的性伴侣(p <0.01),与性伴侣睡觉(p <0.01)、性取向(p = 0.04)和每周性交次数(p <0.01)。在多变量分析中,“没有稳定的性伴侣”仍然是显著的危险因素(p = 0.027, OR = 2.60 [CI 1.11-6.08])。结论在我们的研究中,年轻的墨西哥成年人ED患病率为33.7%,大多数病例是轻度的(17.5%)。合作伙伴的可用性很重要。无有机变量与ED相关。
{"title":"Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability","authors":"C.I. Villeda-Sandoval,&nbsp;M.B. Calao-Pérez,&nbsp;J.O. Herrera-Cáceres,&nbsp;E. González-Cuenca,&nbsp;F. Rodríguez-Covarrubias,&nbsp;R.A. Castillejos-Molina","doi":"10.1016/j.uromx.2015.06.009","DOIUrl":"10.1016/j.uromx.2015.06.009","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the prevalence of ED and associated risk factors among young Mexicans between 18 and 40 years of age.</p></div><div><h3>Methods</h3><p>An observational, cross-sectional, descriptive and analytic study was conducted. Data collection was achieved through a questionnaire. Participants completed the Urologic Health Survey for Men and the International Index of Erectile Function (IIEF-5) questionnaire. The study also included sociodemographic, clinical, and sexual behavior variables.</p></div><div><h3>Results</h3><p>Of the 373 questionnaires filled out, only 160 were answered completely and used for the analysis. The mean age was 25.59<!--> <!-->±<!--> <!-->5.45 years. The prevalence of ED was 33.7% (mild 17.5%, mild-to-moderate 8.1%, moderate 6.3%, and severe 1.9%). The mean score for non-ED males was 24.38<!--> <!-->±<!--> <!-->0.94 versus 15.41<!--> <!-->±<!--> <!-->4.81 in the ED group. Univariate analysis showed a significant difference in the items of age (<em>p</em> <!-->&lt;<!--> <!-->0.01), having a stable sexual partner (<em>p</em> <!-->&lt;<!--> <!-->0.01), sleeping with the sexual partner (<em>p</em> <!-->&lt;<!--> <!-->0.01), sexual orientation (<em>p</em> <!-->=<!--> <!-->0.04), and the number of sexual intercourse episodes per week (<em>p</em> <!-->&lt;<!--> <!-->0.01). In the multivariate analysis “Not having a stable sexual partner” remained a significant risk factor (<em>p</em> <!-->=<!--> <!-->0.027, OR<!--> <!-->=<!--> <!-->2.60 [CI 1.11–6.08]).</p></div><div><h3>Conclusions</h3><p>In our study, young Mexican adults had an ED prevalence of 33.7% and most of the cases were mild (17.5%). Partner availability was important. No organic variables were related to ED.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 260-265"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.06.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128992445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
La eyaculación no tiene impacto en los niveles de antígeno prostático específico 射精对前列腺特异性抗原水平没有影响
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.07.004
M. Ramírez-Bonilla, C.I. Villeda-Sandoval, G. Romero-Vélez, A. Lisker-Cervantes, J.J. Cendejas-Gómez, B. González-Sánchez, D. Olvera-Posada, M. García-Sánchez, R.A. Castillejos-Molina, M. Sotomayor-de Zavaleta

Background

Prostate-specific antigen (PSA) is a tumor marker used in the diagnosis of prostate cancer; it is organ-specific but it is not disease-specific. The effect of ejaculation on PSA concentration is controversial.

Aim

To evaluate the impact of PSA values after ejaculation on biopsy indication in a screened population.

Methods

Baseline PSA was measured in 100 patients that had abstained from sexual activity for at least 7 days. A second measurement was carried out 48 h after ejaculation. The numerical differences were compared using the Student's t test. The McNemar's test was used to analyze pre and post-ejaculation values and clinical significance was defined as a PSA value above a pre-established limit for biopsy indication.

Results

Mean age of the patients was 52.7 ± 8.6 years. The mean baseline PSA was 1.39 ± 1.43 ng/mL and after ejaculation was 1.48 ± 1.51 ng/mL (P = .54). Two patients had PSA values that increased sufficiently for biopsy indication, using a parameter of 4 ng/mL after ejaculation. The McNemar's test showed no statistically significant differences (P = .500).

Conclusions

There was no statistically significant difference in PSA after ejaculation and this change had no clinical relevance.

前列腺特异性抗原(PSA)是一种用于前列腺癌诊断的肿瘤标志物;它是器官特异性的,但不是疾病特异性的。射精对PSA浓度的影响存在争议。目的评价筛查人群射精后PSA值对活检指征的影响。方法对100例禁欲至少7天的患者进行基线PSA测定。第二次测量在射精后48小时进行。采用学生t检验比较数值差异。McNemar试验用于分析射精前和射精后的PSA值,其临床意义定义为PSA值高于预先确定的活检指征限度。结果患者平均年龄52.7±8.6岁。平均基线PSA为1.39±1.43 ng/mL,射精后PSA为1.48±1.51 ng/mL (P = 0.54)。两名患者的PSA值在射精后达到4ng /mL,足以用于活检指示。McNemar检验显示无统计学显著差异(P = .500)。结论射精后PSA水平差异无统计学意义,且无临床意义。
{"title":"La eyaculación no tiene impacto en los niveles de antígeno prostático específico","authors":"M. Ramírez-Bonilla,&nbsp;C.I. Villeda-Sandoval,&nbsp;G. Romero-Vélez,&nbsp;A. Lisker-Cervantes,&nbsp;J.J. Cendejas-Gómez,&nbsp;B. González-Sánchez,&nbsp;D. Olvera-Posada,&nbsp;M. García-Sánchez,&nbsp;R.A. Castillejos-Molina,&nbsp;M. Sotomayor-de Zavaleta","doi":"10.1016/j.uromx.2015.07.004","DOIUrl":"10.1016/j.uromx.2015.07.004","url":null,"abstract":"<div><h3>Background</h3><p>Prostate-specific antigen (PSA) is a tumor marker used in the diagnosis of prostate cancer; it is organ-specific but it is not disease-specific. The effect of ejaculation on PSA concentration is controversial.</p></div><div><h3>Aim</h3><p>To evaluate the impact of PSA values after ejaculation on biopsy indication in a screened population.</p></div><div><h3>Methods</h3><p>Baseline PSA was measured in 100 patients that had abstained from sexual activity for at least 7<!--> <!-->days. A second measurement was carried out 48<!--> <!-->h after ejaculation. The numerical differences were compared using the Student's t test. The McNemar's test was used to analyze pre and post-ejaculation values and clinical significance was defined as a PSA value above a pre-established limit for biopsy indication.</p></div><div><h3>Results</h3><p>Mean age of the patients was 52.7<!--> <!-->±<!--> <!-->8.6<!--> <!-->years. The mean baseline PSA was 1.39<!--> <!-->±<!--> <!-->1.43<!--> <!-->ng/mL and after ejaculation was 1.48<!--> <!-->±<!--> <!-->1.51<!--> <!-->ng/mL (<em>P</em> <!-->=<!--> <!-->.54). Two patients had PSA values that increased sufficiently for biopsy indication, using a parameter of 4<!--> <!-->ng/mL after ejaculation. The McNemar's test showed no statistically significant differences (<em>P</em> <!-->=<!--> <!-->.500).</p></div><div><h3>Conclusions</h3><p>There was no statistically significant difference in PSA after ejaculation and this change had no clinical relevance.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 278-282"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132827046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostatectomía radical laparoscópica y abierta: experiencia en nuestro centro 腹腔镜和开放式根治性前列腺切除术:我们中心的经验
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.06.005
P. Cordeiro, S. Novás, L. Honorato, S. Martínez-Couceiro, C. García-Freire

Aims

At the Complexo Hospitalario Universitario de Santiago de Compostela (Spain), retropubic radical prostatectomy has been performed since 1993 and laparoscopic radical prostatectomy since 2006. We decided to analyze our results and compare the two techniques.

Material and methods

A retrospective observational study was conducted that included all laparoscopic prostatectomies performed within the time frame of January 2011 and September 2013 (62 cases) and all the open prostatectomies performed in 2012 (100 procedures).

Results

We found no statistically significant differences in either the functional (p = 0.15) or oncologic (p = 0.07) results, but there was a statistically significant difference in relation to complications (p = 0.04). The laparoscopic approach is currently the most frequently performed surgical option in our center for the radical approach to prostate cancer.

Conclusions

Laparoscopic radical prostatectomy is a technique with a long learning curve. Nevertheless, we consider that this procedure provides benefits to the patient presenting with prostate cancer, especially with respect to pain, complications, and functional and oncologic results.

在圣地亚哥-德孔波斯特拉大学医院(西班牙),1993年开始实施耻骨后根治性前列腺切除术,2006年开始实施腹腔镜根治性前列腺切除术。我们决定分析我们的结果并比较这两种技术。材料与方法回顾性观察研究纳入2011年1月至2013年9月期间所有腹腔镜前列腺切除术(62例)和2012年所有开放性前列腺切除术(100例)。结果两组患者的功能评分(p = 0.15)和肿瘤评分(p = 0.07)差异无统计学意义,但并发症评分差异有统计学意义(p = 0.04)。腹腔镜手术是目前我们中心最常用的前列腺癌根治性手术。结论腹腔镜根治性前列腺切除术是一项需要长期学习的技术。然而,我们认为这种手术对前列腺癌患者有好处,特别是在疼痛、并发症、功能和肿瘤结果方面。
{"title":"Prostatectomía radical laparoscópica y abierta: experiencia en nuestro centro","authors":"P. Cordeiro,&nbsp;S. Novás,&nbsp;L. Honorato,&nbsp;S. Martínez-Couceiro,&nbsp;C. García-Freire","doi":"10.1016/j.uromx.2015.06.005","DOIUrl":"10.1016/j.uromx.2015.06.005","url":null,"abstract":"<div><h3>Aims</h3><p>At the Complexo Hospitalario Universitario de Santiago de Compostela (Spain), retropubic radical prostatectomy has been performed since 1993 and laparoscopic radical prostatectomy since 2006. We decided to analyze our results and compare the two techniques.</p></div><div><h3>Material and methods</h3><p>A retrospective observational study was conducted that included all laparoscopic prostatectomies performed within the time frame of January 2011 and September 2013 (62 cases) and all the open prostatectomies performed in 2012 (100 procedures).</p></div><div><h3>Results</h3><p>We found no statistically significant differences in either the functional (p<!--> <!-->=<!--> <!-->0.15) or oncologic (p<!--> <!-->=<!--> <!-->0.07) results, but there was a statistically significant difference in relation to complications (p<!--> <!-->=<!--> <!-->0.04). The laparoscopic approach is currently the most frequently performed surgical option in our center for the radical approach to prostate cancer.</p></div><div><h3>Conclusions</h3><p>Laparoscopic radical prostatectomy is a technique with a long learning curve. Nevertheless, we consider that this procedure provides benefits to the patient presenting with prostate cancer, especially with respect to pain, complications, and functional and oncologic results.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 247-252"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127292895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Carcinoma renal de células claras localmente avanzado con tuberculosis renal asociada
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.06.010
S. Collura-Merlier , M. Ramírez-Bonilla , J.M. Ochoa-López , O. Herrera-Cáceres , C. Reyes-Utrera , H. Sandoval-Barba , O. Gómez-Alvarado , C. Cruz-Reyes , R.A. Castillejos-Molina

The association of renal cell carcinoma (RCC) and renal tuberculosis (TB) is uncommon. Whereas the incidental discovery of RCC in tuberculous kidneys is well described, the discovery of tuberculous lesions after radical nephrectomy for cancer is exceptional. The aim of this article was to report a case of locally advanced clear cell RCC whose histologic study revealed associated TB. There are very few published cases of kidney cancer and TB. A case of squamous cell carcinoma of the renal pelvis in a kidney with TB and a case of renal adenocarcinoma and TB have been reported. The present case describes locally advanced RCC with high tumor burden and retroperitoneal adenopathy that, before surgery, suggested metastatic disease to the lymph nodes. However, only histopathologic changes due to TB were found. No clinical or pathologic correlation has been found between these 2 entities, and clinical studies on the subject are lacking.

肾细胞癌(RCC)与肾结核(TB)的关联并不常见。虽然在结核性肾脏中偶然发现的肾细胞癌已经被很好地描述了,但在根治性肾切除术后发现结核性病变是例外。本文的目的是报告一例局部晚期透明细胞癌,其组织学研究显示合并结核。很少有公布的肾癌和结核病病例。本文报告1例肾盂鳞状细胞癌合并结核及1例肾腺癌合并结核。本病例描述了局部晚期肾细胞癌,肿瘤负荷高,腹膜后腺病,术前提示转移到淋巴结。然而,仅发现结核引起的组织病理学改变。在这两种实体之间没有发现临床或病理相关性,并且缺乏关于该主题的临床研究。
{"title":"Carcinoma renal de células claras localmente avanzado con tuberculosis renal asociada","authors":"S. Collura-Merlier ,&nbsp;M. Ramírez-Bonilla ,&nbsp;J.M. Ochoa-López ,&nbsp;O. Herrera-Cáceres ,&nbsp;C. Reyes-Utrera ,&nbsp;H. Sandoval-Barba ,&nbsp;O. Gómez-Alvarado ,&nbsp;C. Cruz-Reyes ,&nbsp;R.A. Castillejos-Molina","doi":"10.1016/j.uromx.2015.06.010","DOIUrl":"10.1016/j.uromx.2015.06.010","url":null,"abstract":"<div><p>The association of renal cell carcinoma (RCC) and renal tuberculosis (TB) is uncommon. Whereas the incidental discovery of RCC in tuberculous kidneys is well described, the discovery of tuberculous lesions after radical nephrectomy for cancer is exceptional. The aim of this article was to report a case of locally advanced clear cell RCC whose histologic study revealed associated TB. There are very few published cases of kidney cancer and TB. A case of squamous cell carcinoma of the renal pelvis in a kidney with TB and a case of renal adenocarcinoma and TB have been reported. The present case describes locally advanced RCC with high tumor burden and retroperitoneal adenopathy that, before surgery, suggested metastatic disease to the lymph nodes. However, only histopathologic changes due to TB were found. No clinical or pathologic correlation has been found between these 2 entities, and clinical studies on the subject are lacking.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 297-300"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.06.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114149879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cirugía Robot Asistida, en Cirugía Reconstructiva 机器人辅助外科,在重建外科
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.09.003
Víctor Enrique Corona Montes
{"title":"Cirugía Robot Asistida, en Cirugía Reconstructiva","authors":"Víctor Enrique Corona Montes","doi":"10.1016/j.uromx.2015.09.003","DOIUrl":"10.1016/j.uromx.2015.09.003","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 245-246"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.09.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114467664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papel de los estrógenos y sus receptores en las enfermedades benignas y malignas prostáticas: Parte 1 雌激素及其受体在前列腺良性和恶性疾病中的作用:第一部分
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.06.007
I. García-Figueredo , M.N. Candia , C.M. Pereda-Meira , C.M. Laborí-Carda

Numerous studies on the molecular basis of prostate cancer focus on the role of androgens, but estrogens have been shown to be linked to prostate cancer development and progression. In the present article, we reviewed the laboratory and clinical evidence, demonstrating that estrogens can be the cause of the development and progression of prostatic hyperplasia and prostate cancer. We also studied the more significant mechanisms related to estrogen action, which include: direct genotoxicity, hyperprolactinemia, inflammation, and receptor-mediated action. In addition, we analyzed the functions of the known estrogen receptors (alpha and beta) in diseases of the prostate. The evidence observed suggests that estrogen receptor alpha plays an essential role in the development of both the normal prostate and the cancer, whereas estrogen receptor beta is related to the differentiation of the prostatic epithelial tissue and numerous antiproliferative actions in prostate cancer. Nevertheless, some of their isoforms are associated with mechanisms of cancer initiation and progression. Finally, we believe that more studies related to estrogen action should be carried out to better understand the role estrogens play in the development of prostate cancer.

许多关于前列腺癌分子基础的研究都集中在雄激素的作用上,但雌激素已被证明与前列腺癌的发生和发展有关。在本文中,我们回顾了实验室和临床证据,证明雌激素可能是前列腺增生和前列腺癌发生发展的原因。我们还研究了与雌激素作用相关的更重要的机制,包括:直接遗传毒性、高催乳素血症、炎症和受体介导的作用。此外,我们分析了已知的雌激素受体(α和β)在前列腺疾病中的功能。观察到的证据表明,雌激素受体α在正常前列腺和前列腺癌的发展中都起着至关重要的作用,而雌激素受体β在前列腺癌中与前列腺上皮组织的分化和许多抗增殖作用有关。然而,它们的一些同工异构体与癌症的发生和发展机制有关。最后,我们认为应该开展更多与雌激素作用相关的研究,以更好地了解雌激素在前列腺癌发展中的作用。
{"title":"Papel de los estrógenos y sus receptores en las enfermedades benignas y malignas prostáticas: Parte 1","authors":"I. García-Figueredo ,&nbsp;M.N. Candia ,&nbsp;C.M. Pereda-Meira ,&nbsp;C.M. Laborí-Carda","doi":"10.1016/j.uromx.2015.06.007","DOIUrl":"10.1016/j.uromx.2015.06.007","url":null,"abstract":"<div><p>Numerous studies on the molecular basis of prostate cancer focus on the role of androgens, but estrogens have been shown to be linked to prostate cancer development and progression. In the present article, we reviewed the laboratory and clinical evidence, demonstrating that estrogens can be the cause of the development and progression of prostatic hyperplasia and prostate cancer. We also studied the more significant mechanisms related to estrogen action, which include: direct genotoxicity, hyperprolactinemia, inflammation, and receptor-mediated action. In addition, we analyzed the functions of the known estrogen receptors (alpha and beta) in diseases of the prostate. The evidence observed suggests that estrogen receptor alpha plays an essential role in the development of both the normal prostate and the cancer, whereas estrogen receptor beta is related to the differentiation of the prostatic epithelial tissue and numerous antiproliferative actions in prostate cancer. Nevertheless, some of their isoforms are associated with mechanisms of cancer initiation and progression. Finally, we believe that more studies related to estrogen action should be carried out to better understand the role estrogens play in the development of prostate cancer.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 283-291"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.06.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126734793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Melanoma en vejiga, reporte de un caso y revisión de la literatura 膀胱黑色素瘤,病例报告及文献综述
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.08.001
L. Casimiro-Guzmán, L.U. Hernández-Román, L.H. Cruz-Contreras, S. Chávez-Martínez

Melanoma of the bladder is a rare malignant neoplasia. Isolated primary cases have been reported, but the most common presentation is metastatic disease. The diagnosis of bladder melanoma is complicated and requires a thorough interdisciplinary study of the patient. In addition, there are no well-standardized histopathologic criteria confirming its primary site. Presented herein is the case of a 42-year-old man with bladder melanoma that manifested as suprapubic pain, dysuria, and weight loss. Both the clinical and histopathologic diagnoses were difficult and it was not possible to determine whether the lesion was a primary one, due to the advanced stage of presentation, as well as to the lack of complementary studies.

膀胱黑色素瘤是一种罕见的恶性肿瘤。孤立的原发病例有报道,但最常见的表现是转移性疾病。膀胱黑色素瘤的诊断是复杂的,需要对患者进行全面的跨学科研究。此外,尚无标准化的组织病理学标准来确定其原发部位。本文报告一例42岁男性膀胱黑色素瘤,表现为耻骨上疼痛、排尿困难和体重减轻。临床和组织病理学诊断都很困难,由于表现阶段较晚,以及缺乏补充研究,无法确定病变是否为原发性病变。
{"title":"Melanoma en vejiga, reporte de un caso y revisión de la literatura","authors":"L. Casimiro-Guzmán,&nbsp;L.U. Hernández-Román,&nbsp;L.H. Cruz-Contreras,&nbsp;S. Chávez-Martínez","doi":"10.1016/j.uromx.2015.08.001","DOIUrl":"10.1016/j.uromx.2015.08.001","url":null,"abstract":"<div><p>Melanoma of the bladder is a rare malignant neoplasia. Isolated primary cases have been reported, but the most common presentation is metastatic disease. The diagnosis of bladder melanoma is complicated and requires a thorough interdisciplinary study of the patient. In addition, there are no well-standardized histopathologic criteria confirming its primary site. Presented herein is the case of a 42-year-old man with bladder melanoma that manifested as suprapubic pain, dysuria, and weight loss. Both the clinical and histopathologic diagnoses were difficult and it was not possible to determine whether the lesion was a primary one, due to the advanced stage of presentation, as well as to the lack of complementary studies.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 306-309"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130369889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Experiencia inicial nefrolitotomía percutánea, posición de Valdivia modificada para el tratamiento quirúrgico en pacientes con litiasis renal 经皮肾碎石切开术,改良瓦尔迪维亚体位手术治疗肾结石患者的初步经验
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.07.001
A. Sánchez-Bermeo, J.R. Arellano-Cuadros, S. García-Cruz, J. Torres-Aguilar, C. Reyes-Vela

Background

Renal lithiasis is a very common pathology that has been described since Hippocrates. Its etiopathogenesis involves different theories on formation that include saturation, oversaturation, crystal nucleation, crystal growth, epitaxis, matrix, crystallization inhibitors, epidemiologic aspects, and heredity. Compared with classic lumbotomy, percutaneous nephrolithotomy is a less aggressive technique facilitating kidney stone treatment. Reduced hospital stay, low analgesic use, and a shorter recovery period make this a well-accepted surgical technique by patients and it is considered the first treatment option in many cases.

Aims

To present the experience at our institution with the modified version of the previously described technique.

Material and methods

All surgical notes on percutaneous nephrolithotomies in the modified Valdivia position performed within the time frame of January to August 2014 were reviewed.

Results

The mean age of the patients was 42 years. Of the 10 patients included in the study, 7 were men and 3 were women. Five of the patients presented with staghorn stones, 2 with pyelic stones, and the rest with pyelic and calyceal stones. Stone size ranged from 2 to 7 cm. A total of 2 (28.6%) stones were in the lower portion of the collecting system, 7 (64%) were in the middle portion, and one (7.1%) was in the upper portion. Estimated surgery duration was a mean of 120.5 min. The complication rate (Clavien-Dindo: I-IV) was 20%, one patient presented with bleeding that was controlled, and 80% of the patients were stone free.

Conclusions

In our experience, percutaneous nephrolithotomy with the modified Valdivia technique is a safe and effective option with a high success rate, anesthesiological advantages, and few complications.

背景:肾结石是一种非常常见的病理,从希波克拉底开始就有描述。其发病机制涉及不同的形成理论,包括饱和、过饱和、晶体成核、晶体生长、外延、基质、结晶抑制剂、流行病学和遗传。与传统的腰切除术相比,经皮肾镜取石术是一种微创的治疗肾结石的技术。住院时间短,镇痛药用量少,恢复期短,这是一种被患者广泛接受的手术技术,在许多情况下被认为是第一种治疗选择。目的介绍本机构对先前描述的技术的改进版本的经验。材料与方法回顾2014年1 - 8月经皮改良Valdivia体位肾镜取石术的手术记录。结果患者平均年龄42岁。在参与研究的10名患者中,7名男性,3名女性。5例为鹿角结石,2例为肾盂结石,其余为肾盂和肾盏结石。石头的大小从2到7厘米不等。收集系统下部2颗(28.6%),中部7颗(64%),上部1颗(7.1%)。估计手术时间平均为120.5分钟。并发症发生率(Clavien-Dindo: I-IV)为20%,1例患者出血得到控制,80%的患者无结石。结论经皮肾镜取石术采用改良的Valdivia技术,成功率高,麻醉优势,并发症少,是一种安全有效的选择。
{"title":"Experiencia inicial nefrolitotomía percutánea, posición de Valdivia modificada para el tratamiento quirúrgico en pacientes con litiasis renal","authors":"A. Sánchez-Bermeo,&nbsp;J.R. Arellano-Cuadros,&nbsp;S. García-Cruz,&nbsp;J. Torres-Aguilar,&nbsp;C. Reyes-Vela","doi":"10.1016/j.uromx.2015.07.001","DOIUrl":"10.1016/j.uromx.2015.07.001","url":null,"abstract":"<div><h3>Background</h3><p>Renal lithiasis is a very common pathology that has been described since Hippocrates. Its etiopathogenesis involves different theories on formation that include saturation, oversaturation, crystal nucleation, crystal growth, epitaxis, matrix, crystallization inhibitors, epidemiologic aspects, and heredity. Compared with classic lumbotomy, percutaneous nephrolithotomy is a less aggressive technique facilitating kidney stone treatment. Reduced hospital stay, low analgesic use, and a shorter recovery period make this a well-accepted surgical technique by patients and it is considered the first treatment option in many cases.</p></div><div><h3>Aims</h3><p>To present the experience at our institution with the modified version of the previously described technique.</p></div><div><h3>Material and methods</h3><p>All surgical notes on percutaneous nephrolithotomies in the modified Valdivia position performed within the time frame of January to August 2014 were reviewed.</p></div><div><h3>Results</h3><p>The mean age of the patients was 42 years. Of the 10 patients included in the study, 7 were men and 3 were women. Five of the patients presented with staghorn stones, 2 with pyelic stones, and the rest with pyelic and calyceal stones. Stone size ranged from 2 to 7<!--> <!-->cm. A total of 2 (28.6%) stones were in the lower portion of the collecting system, 7 (64%) were in the middle portion, and one (7.1%) was in the upper portion. Estimated surgery duration was a mean of 120.5<!--> <!-->min. The complication rate (Clavien-Dindo: I-IV) was 20%, one patient presented with bleeding that was controlled, and 80% of the patients were stone free.</p></div><div><h3>Conclusions</h3><p>In our experience, percutaneous nephrolithotomy with the modified Valdivia technique is a safe and effective option with a high success rate, anesthesiological advantages, and few complications.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 266-271"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127072176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor mixto epitelial y estromal del riñón. Presentación de un caso y revisión de la literatura 肾上皮-间质混合肿瘤。案例介绍和文献综述
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.07.002
M.Á. Bonilla-Becerril , A. Castro-Gaytán , M. García-Gutiérrez , C. Vásquez-Lastra , J. Mérigo-Azpiri , T.P. Nava-López

Mixed epithelial and stromal tumor of the kidney is a rare benign kidney neoplasia that predominantly occurs in middle-aged women. It presents as a well-defined biphasic lesion with solid and cystic components in both tomography and magnetic resonance imaging, reflecting the proliferation of the stromal element and the presence of multiple cysts that are the manifestation of the epithelial element. Malignant transformation, recurrence, and metastasis are rare, but isolated cases and small series have been reported in the literature.

肾上皮和间质混合瘤是一种罕见的良性肾脏肿瘤,主要发生于中年妇女。在断层扫描和磁共振成像中表现为明确的双相病变,有实性和囊性成分,反映了间质成分的增殖和多个囊肿的存在,这些囊肿是上皮成分的表现。恶性转化、复发和转移是罕见的,但在文献中有个别病例和小系列的报道。
{"title":"Tumor mixto epitelial y estromal del riñón. Presentación de un caso y revisión de la literatura","authors":"M.Á. Bonilla-Becerril ,&nbsp;A. Castro-Gaytán ,&nbsp;M. García-Gutiérrez ,&nbsp;C. Vásquez-Lastra ,&nbsp;J. Mérigo-Azpiri ,&nbsp;T.P. Nava-López","doi":"10.1016/j.uromx.2015.07.002","DOIUrl":"10.1016/j.uromx.2015.07.002","url":null,"abstract":"<div><p>Mixed epithelial and stromal tumor of the kidney is a rare benign kidney neoplasia that predominantly occurs in middle-aged women. It presents as a well-defined biphasic lesion with solid and cystic components in both tomography and magnetic resonance imaging, reflecting the proliferation of the stromal element and the presence of multiple cysts that are the manifestation of the epithelial element. Malignant transformation, recurrence, and metastasis are rare, but isolated cases and small series have been reported in the literature.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 301-305"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133721326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-dose piperacillin/tazobactam as prophylaxis in transrectal prostate biopsy 单剂量哌拉西林/他唑巴坦在经直肠前列腺活检中的预防作用
Q4 Medicine Pub Date : 2015-09-01 DOI: 10.1016/j.uromx.2015.07.003
J.O. Herrera-Caceres , C.I. Villeda-Sandoval , J. Ruiz-Quiñones , P. De-La-Rosa-Leiva , R.A. Castillejos-Molina , G. Feria-Bernal , A. Galindo-Fraga , F. Rodriguez-Covarrubias

Background

The increasing resistance to quinolones has led to the consideration of other antibiotic options for the prevention of infectious complications in prostate biopsy. We present our experience using a single dose of piperacillin/tazobactam as prophylaxis.

Methods

A retrospective study of transrectal prostate biopsies performed at our institution from 2008 to 2013 was conducted. All patients received enemas before biopsy and a single 4.5 g dose of piperacillin/tazobactam was administered i.v. a few minutes before the biopsy. Clinical and microbiological variables were analyzed to find out risk factors for complications.

Results

A total of 543 biopsies were included. Ninety-two complications (16.9%) were reported in 74 (13.6%) patients, 4.2% of which were infectious complications. In these patients, the associated risk factors were a previous history of positive urine cultures within a 3-year period before biopsy, the presence of a transurethral indwelling catheter at the time of the biopsy, hospital admission within a month before biopsy, and a preoperative positive urine culture despite antibiotic therapy selected according to the resistance pattern.

Conclusions

Physicians and patients should be aware of the risk for complications, particularly if risk factors are present. A single dose of piperacillin/tazobactam is a reasonable option for prophylaxis, especially in countries with a high prevalence of quinolone-resistant pathogens.

背景:对喹诺酮类药物耐药性的增加导致考虑其他抗生素的选择,以预防前列腺活检中的感染性并发症。我们介绍我们使用单剂量哌拉西林/他唑巴坦作为预防的经验。方法回顾性分析2008 ~ 2013年在我院行经直肠前列腺活检的病例。所有患者在活检前均接受灌肠,并在活检前几分钟静脉注射单剂量4.5 g哌拉西林/他唑巴坦。分析临床和微生物变量,找出并发症的危险因素。结果共纳入543例活组织检查。74例(13.6%)患者报告92例(16.9%)并发症,其中4.2%为感染性并发症。在这些患者中,相关的危险因素是活检前3年内尿培养阳性病史,活检时存在经尿道留置导管,活检前1个月内住院,术前尿培养阳性,尽管根据耐药性模式选择了抗生素治疗。结论医生和患者应意识到并发症的风险,特别是如果存在危险因素。单剂量哌拉西林/他唑巴坦是一种合理的预防选择,特别是在喹诺酮耐药病原体高发的国家。
{"title":"Single-dose piperacillin/tazobactam as prophylaxis in transrectal prostate biopsy","authors":"J.O. Herrera-Caceres ,&nbsp;C.I. Villeda-Sandoval ,&nbsp;J. Ruiz-Quiñones ,&nbsp;P. De-La-Rosa-Leiva ,&nbsp;R.A. Castillejos-Molina ,&nbsp;G. Feria-Bernal ,&nbsp;A. Galindo-Fraga ,&nbsp;F. Rodriguez-Covarrubias","doi":"10.1016/j.uromx.2015.07.003","DOIUrl":"10.1016/j.uromx.2015.07.003","url":null,"abstract":"<div><h3>Background</h3><p>The increasing resistance to quinolones has led to the consideration of other antibiotic options for the prevention of infectious complications in prostate biopsy. We present our experience using a single dose of piperacillin/tazobactam as prophylaxis.</p></div><div><h3>Methods</h3><p>A retrospective study of transrectal prostate biopsies performed at our institution from 2008 to 2013 was conducted. All patients received enemas before biopsy and a single 4.5<!--> <!-->g dose of piperacillin/tazobactam was administered i.v. a few minutes before the biopsy. Clinical and microbiological variables were analyzed to find out risk factors for complications.</p></div><div><h3>Results</h3><p>A total of 543 biopsies were included. Ninety-two complications (16.9%) were reported in 74 (13.6%) patients, 4.2% of which were infectious complications. In these patients, the associated risk factors were a previous history of positive urine cultures within a 3-year period before biopsy, the presence of a transurethral indwelling catheter at the time of the biopsy, hospital admission within a month before biopsy, and a preoperative positive urine culture despite antibiotic therapy selected according to the resistance pattern.</p></div><div><h3>Conclusions</h3><p>Physicians and patients should be aware of the risk for complications, particularly if risk factors are present. A single dose of piperacillin/tazobactam is a reasonable option for prophylaxis, especially in countries with a high prevalence of quinolone-resistant pathogens.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"75 5","pages":"Pages 272-277"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130469232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Revista mexicana de urologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1